Eli Lilly and Novo Nordisk dominate the billion-dollar weight loss drug market. Lilly has announced positive trial results ...

A WOMAN who weighed 12st 10lbs and was a size 16 decided to try the weight loss jab after struggling to stick to diets, but things weren’t as perfect as she’d hoped. Kathleen Smith, ...

Novo Nordisk's are known as GLP-1 receptor agonists, while Lilly's drugs are dual GIP/GLP-1 receptor agonists -- in both cases, they act on hormones involved in the digestion process, regulating ...

So during digestion, food is broken down into smaller ... GLP-1, as well as a second hormone called GIP, glucose-dependent insulinotropic polypeptide -- You don't need to remember all this ...

“With the recent development of GLP-1 receptor agonists and GIP agonists, which have really been a huge advancement in health and help people lose weight, I think we shouldn’t forget about ...

Discover Mounjaro Tirzepatide's impact on obesity in India post its March launch. Get insights on effectiveness against ...